Pathway-Centric Tools and Technology™

What Pathway-Centric Tools and Technology Can Do for You?

We often use the phrase pathway-centric to describe our approach to designing and developing research tools for the life science researcher. But what do we mean by pathway-centric, and what do pathway-centric tools do for you?

Pathway-Centric tools are simply life science research tools whose content is specific to one biological pathway or gene family. The essential benefits of our pathway-centric philosophy are twofold:

  1. ready-to-use kits based on current understanding of gene relevance saves the significant time our research customers may spend trying to identify exactly which genes are relevant in the pathway(s) involved with the disease or cell function under study,
  2. focusing on the same important pathways and gene families with three technology platforms - cDNA microarrays, RT-PCR, and siRNA - greatly simplifies the task of verifying and extending initial results.

For example, using this pathway-centric set of complementary tools, a researcher can quickly plan and execute an investigation:

  1. to determine relative apoptosis-related gene expression profiles of normal and diseased samples with the Q Series Human Apoptosis Gene Array,
  2. to independently verify the expression profile of those same apoptosis-related genes individually with SingleGene PCR Kits or as gene families with MultiGene-12 PCR Kits,
  3. to knock down the expression of those same apoptosis-related genes individually with SureSilencing™ siRNA Kits or as gene families with our new siRNA Array Plates,
  4. to repeat the gene expression profile of apoptosis-related genes with the Q Series Human Apoptosis Gene Array.

The planned gene overlap among the three sets of tools accelerates the study of important disease state and cell function pathways. Additionally, the pathway-specific organization of our research tools simplifies project planning, allows for quicker execution of experiments and lowers the overall cost of experimentation.

Other technology platforms may be added to our line of research tools in the future. However, providing a complementary set of pathway-centric tools will remain constant in the SABiosciences philosophy.

Article: 1      2      3      4